FDA.reportPublic FDA data

Fluzone 2025-2026 trivalent vaccine Injectable Suspension

RxCUI
2719216
RxNorm name
Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Display name
Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Full name
Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103914Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone QuadrivalentInfluenza Virus Vaccine351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5fe0ce14-bc11-4b43-b002-7efdca0d3003Fluzone 2025-2026 trivalent vaccine Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2025-2026] [SBD] · Fluzone 2025-2026 trivalent vaccine Injectable Suspension [SY]312These highlights do not include all the information needed to use Fluzone® safely and effectively. See full prescribing information for Fluzone. Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2025–2026 Formula Initial U.S. Approval: 198020260325